Not two weeks af­ter clos­ing a Se­ries D round, Galec­to files for $100M IPO

Galec­to Biotech is piv­ot­ing to the pub­lic mar­ket less than two weeks af­ter com­plet­ing a $64 mil­lion Se­ries D round.

The Copen­hagen-based com­pa­ny filed its S-1 pa­per­work Wednes­day, seek­ing to raise $100 mil­lion in its IPO. If they hit that bench­mark, the com­pa­ny will have to­taled over $250 mil­lion in fi­nanc­ing in the last two years, ever since clos­ing a $90 mil­lion Se­ries C back in 2018.

Through late Au­gust, the biotech in­dus­try had raised a com­bined $11 bil­lion-plus across four dozen IPOs, per in­de­pen­dent an­a­lyst Brad Lon­car, which sur­passed the amount from all of 2019.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER